| Pfizer AG - Talzenna 0.25 mg, Hartkapseln | | 67141 | | 01 | | Talzenna 0.25 mg | | Hartkapseln | | L01XK04 | | Talazoparib | | 12.12.2019 | | |
| | Composition | | talazoparibum 0.25 mg ut talazoparibi tosilas, cellulosum microcristallinum silicificatum, Kapselhülle: hypromellosum, E 171, E 172 (flavum), Drucktinte: lacca, propylenglycolum, ammonii hydroxidum, E 172 (nigrum), kalii hydroxidum, pro capsula. | | Packungsbestandteile | | Capsules | | | | | Principe actif | Concentr. |
|---|
| Talazoparibum | 0.25 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Talazoparibum | 0.25 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| (Flavum) | | | | (Nigrum) | | | | Ammonii Hydroxidum | | | | Cellulosum Microcristallinum Silicificatum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Kapselhülle | | Kalii Hydroxidum | | | | Lacca | | Drucktinte | | Pro Capsula | | | | Propylenglycol | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | 30 | 1557.04 | 1709.80 | A | LS | Oui |
|
|
